Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Royalty Pharma plc (RPRX)
Market Closed
17 Jul, 20:00
NASDAQ (NGS)
All
(6)
DE
(5)
US
(1)
NASDAQ (NGS)
Primary
XSTU
XDUS
XMUN
XFRA
XETRA
$
58.
18
-0.35
-0.598%
$
23.94B
Market Cap
11.13
P/E Ratio
0.84%
Div Yield
2.54M
Volume
3.8
Eps
$
58.53
Previous Close
Investors:
TJD
CE
ABB
JD
+107
Analysts:
GM
SS
Watching
Watch
Add Transaction
Day Range
58.12
59.44
Year Range
34.08
59.44
Want to track
RPRX
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Statistics
News
Historical Data
Investors
Analysts
Royalty Pharma plc (RPRX) Statistics
Valuation metrics
Market Cap
23.94B
Enterprise value
33.39B
Trailing P/E (ttm)
23.61
Forward P/E
-
PEG ratio
-58.32
Price/Sales (ttm)
10.25
Price/Book (mrq)
3.65
Enterprise Value/Revenue
13.68
Enterprise Value/EBITDA
19.66
Overview
Shares outstanding
-
Float
-
Shares short
-
% Held by insiders
-
% Held by institutions
-
Average volume (10 days)
2.19M
Average volume (90 days)
3.36M
Price summary
52-Week low
34.08
52-Week high
59.44
Beta
-
50-Day moving average
55.66
200-Day moving average
46.39
Dividends and splits
Forward annual dividend rate
-
Forward annual dividend yield
-
Trailing annual dividend rate
0.91
Trailing annual dividend yield
0.0156%
5-Year annual dividend yield
-
Payout ratio
0.47
Dividend Date
10 Jun 2026
Ex-Dividend Date
15 May 2026
Last split factor
-
Last split Date
-
Financials
Fiscal year
Fiscal year ends
-
Most recent quarter (mrq)
-
Profitability
Profit margin
0.34%
Operating margin
0.68%
Operational effectiveness
Return on assets
0.04%
Return on equity
0.13%
Income Statement
Revenue (ttm)
-
Revenue per share (ttm)
5.65
Quarterly revenue growth (yoy)
-
Gross profit (ttm)
-
EBITDA
-
Net income to common (ttm)
-
Diluted EPS (ttm)
1.92
Quarterly earnings growth (yoy)
-
Balance Sheet
Total cash (mrq)
-
Total cash per share (mrq)
1.41
Total debt (mrq)
-
Total Debt/Equity (mrq)
1.3
Current ratio (mrq)
2.66%
Book value per share (mrq)
23.01
Cash Flow
Cash flow statement
-
Levered free cash flow (LFCF)
-